CHU de Nîmes
Nîmes, 30029, France
NCT Number: NCT04009707
The objective of this study is therefore to compare the results obtained with these two screening tests, using as gold standard the results obtained by the battery of neuropsychological reference tests.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nîmes, 30029, France
Recently, a new screening test for cognitive disorders was specifically developed for patients with UAS: BEARNI (Brief Evaluation of Alcohol-Related Neuropsychological Impairments). Since the BEARNI is presented as the reference test, the investigators have systematically proposed it to hospitalized patients, in combination with the usual check-up. In practice, at admission, patients were therefore given two screening tests, the MoCA and the BEARNI. In the event of an anomaly in at least one of these tests, a battery of confirmatory neuropsychological tests was performed.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the MoCA questionnaire is used to assess cognitive disorders
This questionnaire is used to assess cognitive disorders
Time frame: Day 1 (only 1 time)
comparison of the sensitivity of the 2 tests against the gold standard
Time frame: Day 1 (only 1 time)
comparison of the specificity of the 2 tests against the gold standard
Centre Hospitalier Universitaire de Nīmes
Other
Comparison of 2 Tests for Screening for Cognitive Disorders (MoCA / BEARNI)
Acronym: MoCA/BEARNI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04523922
Alcohol Use Disorder, Alcohol-Related Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT06817356
Alcohol Use Disorder, Alcohol-Related Disorders
Scottsdale, Arizona, United States
View Trial DetailsNCT05630118
Alcohol Use Disorder, Alcohol-Related Disorders
Lexington, Kentucky, United States
View Trial DetailsNCT06545929
Alcohol Use Disorder, Alcohol-Related Disorders
Columbus, Ohio, United States
View Trial Details